Volume 82 Issue 24
Issue Date: June 14, 2004
p. 17 ConcentratesIssue Date: June 14, 2004
Contract firms strike deals
Department: Business
Three fine chemicals companies have reached contract-manufacturing agreements with drug industry partners. In the small-molecule realm, Lonza will produce Isotechnika's trans-ISA247, an immunosuppressant, for use in upcoming clinical trials. In biopharmaceuticals, Biovitrum will manufacture Maxygen's improved form of interferon ß, a multiple sclerosis drug, for Phase I and II clinical trials. And also in biopharma, Akzo Nobel's Diosynth unit will make clinical quantities of a therapeutic monoclonal antibody for Human Genome Sciences.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society
Leave A Comment